Pfizer Inc. beat EPS estimates 95% of the time across 20 reported quarters (19 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.68 | $0.77 | +13.2% | Beat |
| Q12026 FY2026 | $0.71 | $0.75 | +5.6% | Beat |
| Q42025 FY2025 | $0.57 | $0.66 | +15.8% | Beat |
| Q42024 FY2024 | $0.47 | $0.63 | +33.6% | Beat |
| Q42023 FY2023 | $-0.19 | $0.10 | +152.6% | Beat |
| Q3 FY2023 | $-0.32 | $-0.17 | +46.9% | Beat |
| Q2 FY2023 | $0.56 | $0.67 | +19.6% | Beat |
| Q1 FY2023 | $0.98 | $1.23 | +25.5% | Beat |
| Q42022 FY2022 | $1.05 | $1.14 | +8.6% | Beat |
| Q32022 FY2022 | $1.39 | $1.78 | +28.1% | Beat |
| Q22022 FY2022 | $1.78 | $2.04 | +14.6% | Beat |
| Q12022 FY2022 | $1.47 | $1.67 | +13.6% | Beat |
Back to PFE overview · PFE holders · PFE KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.